搜尋結果
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 4 日前Vaccine makers should consider targeting one of the currently dominant JN.1 variants and ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 4 日前Moderna and Merck released more positive three-year data Monday on their experimental vaccine, ...
Noubar Afeyat MIT Commencement: Imagination – And Action!
Forbes· 4 日前Noubar Afeyat delivered some very relevant remarks, in my opinion, at this year’s MIT ...
CNBC Daily Open: Opec extends cuts, Nvidia showcases new chip
CNBC· 4 日前OPEC and it allies agreed to extend official crude production cuts into 2025 amid lackluster ...
As China’s influence grows, Malaysia’s wounds over 1969 race riots heal slowly
South China Morning Post· 5 日前“Everyone [is] just going about their business, but beneath the everyday hum of activity is a ...
Experts predict impending summer influenza surge next month, H3 virus may resurface
Dimsum Daily· 6 日前1st June 2024 – (Hong Kong) In a recent report titled “COVID-19 & Flu Express” published by ...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 7 日前, opens new tab respiratory syncytial virus (RSV) vaccine, the company announced on Friday, ...
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 7 日前Moderna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines ...
South Africa's Ramaphosa badly weakened by ANC election slump
Reuters· 7 日前South African President Cyril Ramaphosa will be badly weakened after presiding over the African ...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 7 日前The Food and Drug Administration on Friday approved Moderna's vaccine for respiratory ...